The Effect of CYP2D6 Phenotypes on the Pharmacokinetics of Propafenone: A Systematic Review and Meta-Analysis
Propafenone (PPF) is a class 1C antiarrhythmic agent mainly metabolized by cytochrome (CYP) 2D6, CYP1A2, and CYP3A4. Previous studies have shown that CYP2D6 polymorphism influences the pharmacokinetics (PK) of PPF. However, the small sample sizes of PK studies can lead to less precise estimates of t...
Main Authors: | Quyen Thi Tran, In-hwan Baek, Na-young Han, Hwi-yeol Yun, Jung-woo Chae |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/7/1446 |
Similar Items
-
Pharmacokinetics of propafenone hydrochloride sustained-release capsules in male beagle dogs
by: Liping Pan, et al.
Published: (2015-01-01) -
Suicide attempt of young woman by Propafenone overdose - case report
by: Marcin Wais, et al.
Published: (2023-12-01) -
Propafenone Induced Takotsubo Cardiomyopathy: A Mere Coincidence or A New Causal Relationship?
by: Adem Adar, et al.
Published: (2023-12-01) -
Severe cardiac toxicity following alcohol intake in a patient using therapeutic dose of propafenone
by: Zübeyde Bayram, et al.
Published: (2017-12-01) -
Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)